A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 265,455 shares of TEVA stock, worth $4.54 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
265,455
Previous 135,092 96.5%
Holding current value
$4.54 Million
Previous $1.79 Billion 99.76%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $1.67 Million - $2.27 Million
130,363 Added 96.5%
265,455 $4.31 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $1.44 Million - $1.95 Million
135,092 New
135,092 $1.79 Billion
Q4 2023

Aug 14, 2024

SELL
$8.12 - $10.63 $48,638 - $63,673
-5,990 Reduced 6.54%
85,617 $894 Million
Q3 2023

Aug 14, 2024

SELL
$7.48 - $10.7 $46,346 - $66,297
-6,196 Reduced 6.34%
91,607 $934 Million
Q2 2023

Aug 14, 2024

BUY
$7.2 - $9.47 $46,994 - $61,810
6,527 Added 7.15%
97,803 $736 Million
Q1 2023

Aug 14, 2024

SELL
$8.36 - $11.37 $145,622 - $198,054
-17,419 Reduced 16.03%
91,276 $808 Million
Q4 2022

Aug 14, 2024

SELL
$7.95 - $9.48 $7,743 - $9,233
-974 Reduced 0.89%
108,695 $991 Million
Q3 2022

Aug 14, 2024

SELL
$6.86 - $11.95 $16,464 - $28,680
-2,400 Reduced 2.14%
109,669 $885 Million
Q2 2022

Aug 14, 2024

BUY
$7.38 - $10.4 $167,850 - $236,537
22,744 Added 25.46%
112,069 $843 Million
Q1 2022

Aug 14, 2024

SELL
$7.33 - $9.39 $1.29 Million - $1.65 Million
-176,130 Reduced 66.35%
89,325 $839 Million
Q4 2021

Aug 30, 2024

SELL
$7.9 - $10.19 $7,884 - $10,169
-998 Reduced 1.07%
92,104 $738 Million
Q3 2021

Aug 30, 2024

SELL
$8.38 - $10.18 $25,600 - $31,099
-3,055 Reduced 3.18%
93,102 $907 Million
Q2 2021

Aug 30, 2024

SELL
$9.9 - $11.56 $1.68 Million - $1.96 Million
-169,298 Reduced 63.78%
96,157 $952 Million
Q1 2021

Aug 30, 2024

BUY
$10.34 - $12.81 $44,710 - $55,390
4,324 Added 4.26%
105,906 $1.22 Billion
Q4 2020

Aug 30, 2024

SELL
$8.61 - $11.04 $1.47 Million - $1.89 Million
-170,937 Reduced 62.72%
101,582 $980 Million
Q3 2020

Aug 30, 2024

BUY
$8.57 - $12.69 $117,486 - $173,967
13,709 Added 5.3%
272,519 $2.46 Billion
Q2 2020

Aug 30, 2024

SELL
$8.12 - $13.12 $1.7 Million - $2.75 Million
-209,557 Reduced 44.74%
258,810 $3.19 Billion
Q1 2020

Aug 30, 2024

SELL
$6.69 - $13.45 $116,252 - $233,720
-17,377 Reduced 3.58%
468,367 $4.21 Billion
Q4 2019

Aug 30, 2024

BUY
$6.53 - $10.72 $14,359 - $23,573
2,199 Added 0.45%
485,744 $4.76 Billion
Q3 2019

Aug 30, 2024

BUY
$6.16 - $9.6 $655,060 - $1.02 Million
106,341 Added 28.19%
483,545 $3.33 Billion
Q2 2019

Aug 30, 2024

BUY
$8.12 - $15.72 $1.22 Million - $2.37 Million
150,839 Added 66.64%
377,204 $3.48 Billion
Q1 2019

Aug 30, 2024

BUY
$15.58 - $20.01 $352,918 - $453,266
22,652 Added 11.12%
226,365 $3.55 Billion
Q4 2018

Aug 30, 2024

SELL
$14.59 - $23.84 $900,815 - $1.47 Million
-61,742 Reduced 23.26%
203,713 $3.14 Billion
Q3 2018

Aug 30, 2024

SELL
$21.06 - $25.65 $50,628 - $61,662
-2,404 Reduced 1.23%
192,598 $4.15 Billion
Q2 2018

Aug 30, 2024

SELL
$16.77 - $24.71 $746,080 - $1.1 Million
-44,489 Reduced 18.58%
195,002 $4.74 Billion
Q1 2018

Aug 30, 2024

BUY
$16.68 - $22.07 $555,227 - $734,644
33,287 Added 16.14%
239,491 $4.09 Billion
Q4 2017

Aug 30, 2024

BUY
$11.23 - $19.1 $73,534 - $125,066
6,548 Added 3.28%
206,204 $3.91 Billion
Q3 2017

Aug 30, 2024

BUY
$15.41 - $32.17 $489,467 - $1.02 Million
31,763 Added 18.92%
199,656 $3.51 Billion
Q2 2017

Aug 30, 2024

BUY
N/A
5,260 Added 3.23%
167,893 $5.58 Billion
Q1 2017

Aug 30, 2024

SELL
N/A
-102,822
162,633 $5.22 Billion

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.